VALOP-500 CR TABLETS
VALOP-500 CR TABLETS
Product Details :
| Feature | Details |
|---|---|
| Product Name | VALOP-500 CR Tablets |
| Form | Controlled Release Tablets |
| Key Ingredients | Sodium Valproate + Valproic Acid (total 500 mg) |
| Core Benefits | Seizure control, mood stabilization, migraine prevention |
| Mechanism of Action | Increases brain GABA levels to stabilize electrical activity |
| Support Areas | Epilepsy, bipolar disorder, migraine prophylaxis |
| Recommended Usage | As directed by a neurologist or physician |
Composition: Sodium Valproate 333and Valproic Acid controlled release 145mg Packing: 10X10 Alu-Alu Description : VALOP-500 CR Tablets contain Sodium Valproate and Valproic Acid (combined 500 mg) in a controlled-release (CR) formulation. It is widely used for managing epilepsy, bipolar disorder, and migraine prophylaxis. The CR technology ensures a steady release of medication throughout the day, improving seizure control and mood stability while minimizing side effects. VALOP-500 CR is effective as monotherapy or in combination with other antiepileptics. It provides long-term neurological support and is well-tolerated under proper medical supervision.